Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Roundup

April 10, 2006 | A version of this story appeared in Volume 84, Issue 15

Novartis has raised its offer for the stock of Chiron that it does not already own to $48 per share from $45. This move effectively ends a shareholder revolt against the merger, according to analysts.

Chemtura is selling its industrial water additives business, excluding its Liquibrom line, to a U.K.-based private equity firm. The business had sales last year of about $80 million.

India's Shasun Chemicals & Drugs has completed its acquisition of Rhodia's custom synthesis business (C&EN, Jan. 16, page 5). The deal includes ChiRex, a business for which Rhodia paid $545 million in 2000.

Merisol, a 50-50 joint venture of Sasol and Merichem specializing in cresylics, will increase m-cresol capacity by 20% at its Oil City, Pa., plant by early 2007. Merisol, which also makes the product in Winnie, Texas, says it supplies a third of global m-cresol demand.

DSM Venturing has participated in a follow-on financing round of $6.5 million for the personalized nutrition company Sciona. As a result, DSM is now a major shareholder in the firm.

Lyondell Chemical and Citgo Petroleum, a subsidiary of Venezuelan state oil company PDVSA, want to sell their Lyondell-Citgo Refining joint venture, which operates a heavy crude oil refinery in Houston. The sale would make Lyondell solely a chemical company.

Akzo Nobel has offered $17.09 per share to acquire Sico Inc., which it calls Canada's leading coatings company. The value of the deal would be about $250 million. Akzo says Sico's two largest shareholders have agreed to sell their shares.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.